Oct 31, 2018
PDL BioPharma to Announce Third Quarter Financial Results on November 6, 2018
Oct 08, 2018
PDL BioPharma Names Edward Imbrogno Vice President of Finance
Sep 26, 2018
PDL BioPharma to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
Aug 30, 2018
PDL BioPharma to Present at the H.C. Wainwright 20th Annual Global Investment Conference
Aug 08, 2018
PDL BioPharma Reports Second Quarter 2018 Financial Results
Aug 02, 2018
PDL BioPharma Acquires Depomed's Remaining 50% Interest in Royalties and Milestones on Type 2 Diabetes Products
Jun 22, 2018
Elizabeth O'Farrell Named to PDL BioPharma's Board of Directors
Jun 11, 2018
Shlomo Yanai Elected to PDL BioPharma's Board of Directors
May 21, 2018
PDL BioPharma Names Dr. Jill Jene Vice President, Business Development
May 15, 2018
PDL BioPharma to Present at Two Upcoming Investor Conferences
May 09, 2018
PDL BioPharma Announces First Quarter 2018 Financial Results
May 02, 2018
PDL BioPharma to Announce First Quarter 2018 Financial Results on May 9, 2018
Apr 03, 2018
PDL BioPharma to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 08, 2018
PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results
Mar 01, 2018
PDL BioPharma to Announce Fourth Quarter / Year-End 2017 Financial Results on March 8, 2018
Feb 20, 2018
PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos
Feb 14, 2018
PDL BioPharma to Present at Two Upcoming Investor Conferences
Nov 08, 2017
PDL BioPharma's Proposal to Acquire Neos Therapeutics Expires Today; PDL Urges Neos to Provide Update on Sale Process
Nov 07, 2017
PDL BioPharma to Present at Two Upcoming Investor Conferences
Nov 02, 2017
PDL BioPharma Announces Third Quarter 2017 Financial Results